Integrated neglected tropical disease control and elimination programs: A global health 'best buy'

A recently released report, entitled "Social and Economic Impact Review on Neglected Tropical Diseases," highlights links between neglected tropical diseases (NTDs) and socio-economic prosperity. Published by Hudson Institute's Center for Science in Public Policy, in partnership with the Global Network for Neglected Tropical Diseases, an initiative of the Sabin Vaccine Institute, the paper found NTD control and elimination efforts to be both inexpensive and highly effective, especially when paired with other major disease treatment efforts, making NTD programs one of the most cost-effective public health interventions available.

"Based on our efforts in compiling this review, we can say with confidence that NTD control and elimination is one of the best buys in global public health," said Dr. Jeremiah Norris, director of the Center for Science in Public Policy at Hudson Institute. "The crucial next step is to use this evaluation as a catalyst for prioritizing NTD programs worldwide."

NTDs are a group of parasitic and that infect more than 1 billion people around the world, most of whom live below the poverty line. These diseases cause malnutrition and anemia, , blindness, disfigurement and delays to physical and among children, often perpetuating the poverty of those they infect. For a cost of approximately 50 cents per person annually, a packet of pills can treat and protect against these diseases. Pharmaceutical companies donate most of the treatments and many programs use existing infrastructure, such as schools and community centers, to administer them.

Despite their wide-spread impact and low treatment cost, NTDs have been categorized as "other diseases" on the global health and development agenda and often exist in the shadow of better-known diseases such as HIV/AIDS, tuberculosis and malaria. Based on their findings, the report's authors outlined key recommendations for reducing the burden of NTDs and meeting elimination targets, including prioritizing integrated programs, pivoting from an exclusive health focus to a broader socio-economic context and expanding the role of corporate and public-private partnerships.

"This new report provides strong evidence of the larger socio-economic impact that NTDs have on infected communities," said Dr. Neeraj Mistry, managing director of the Global Network for . "By following the report's recommendations, we can build broader awareness and the political will necessary to put NTDs at the top of the global development agenda—improving the health and prosperity for more than a billion people currently suffering from these devastating diseases."

Related Stories

Recommended for you

'Ebola will return', veteran scientist warns

date 7 hours ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

date 23 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.